David Hojnacki

1.1k total citations
32 papers, 849 citations indexed

About

David Hojnacki is a scholar working on Neurology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, David Hojnacki has authored 32 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 15 papers in Pathology and Forensic Medicine and 5 papers in Neurology. Recurrent topics in David Hojnacki's work include Multiple Sclerosis Research Studies (15 papers), Cerebral Venous Sinus Thrombosis (13 papers) and Peripheral Neuropathies and Disorders (4 papers). David Hojnacki is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Cerebral Venous Sinus Thrombosis (13 papers) and Peripheral Neuropathies and Disorders (4 papers). David Hojnacki collaborates with scholars based in United States, Italy and Canada. David Hojnacki's co-authors include Bianca Weinstock‐Guttman, Robert Zivadinov, Michael G. Dwyer, Ellen Carl, Cheryl Kennedy, Niels Bergsland, Karen Marr, Christopher Magnano, Jesper Hagemeier and Murali Ramanathan and has published in prestigious journals such as Applied and Environmental Microbiology, Neurology and BMC Medicine.

In The Last Decade

David Hojnacki

31 papers receiving 813 citations

Peers

Countries citing papers authored by David Hojnacki

Since Specialization

Citations

This map shows the geographic impact of David Hojnacki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hojnacki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hojnacki more than expected).

Fields of papers citing papers by David Hojnacki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hojnacki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hojnacki. The network helps show where David Hojnacki may publish in the future.

Co-authorship network of co-authors of David Hojnacki

This figure shows the co-authorship network connecting the top 25 collaborators of David Hojnacki. A scholar is included among the top collaborators of David Hojnacki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hojnacki. David Hojnacki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Determinants of long‐term paramagnetic rim lesion evolution in people with multiple sclerosis 2024 ·Annals of Clinical and Translational Neurology ·(unknown), (unknown), Maryam Mohebbi, Murali Ramanathan, Niels Bergsland, Dejan Jakimovski, Gregory E. Wilding, (unknown), Ferdinand Schweser, Bianca Weinstock‐Guttman, David Hojnacki, Svetlana Eckert, Francesca Bagnato, Michael G. Dwyer, Robert Zivadinov	3
2	Tixagevimab and Cilgavimab (Evusheld™) Prophylaxis Prevents Breakthrough COVID-19 Infections in Immunosuppressed Population: 6-Month Prospective Study 2023 ·Vaccines ·Dejan Jakimovski, Svetlana Eckert, Omid Mirmosayyeb, (unknown), (unknown), David Hojnacki, Bianca Weinstock‐Guttman	9
3	Detecting isolated cognitive relapses in persons with MS 2023 ·Multiple Sclerosis Journal ·Sarah A. Morrow, (unknown), Omid Mirmosayyeb, Devon Conway, Tom Fuchs, (unknown), (unknown), David Hojnacki, Michael G. Dwyer, Robert Zivadinov, Bianca Weinstock‐Guttman, Ralph H. B. Benedict	7
4	COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections 2022 ·Vaccines ·Dejan Jakimovski, (unknown), (unknown), Katelyn Kavak, (unknown), David Hojnacki, Channa Kolb, (unknown), Svetlana Eckert, (unknown), (unknown), Keith R. Edwards, Bianca Weinstock‐Guttman	15
5	Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes 2021 ·NeuroImage Clinical ·Dejan Jakimovski, Robert Zivadinov, Niels Bergsland, Deepa P. Ramasamy, Jesper Hagemeier, (unknown), David Hojnacki, Bianca Weinstock‐Guttman, Michael G. Dwyer	7
6	Late onset multiple sclerosis is associated with more severe ventricle expansion 2020 ·Multiple Sclerosis and Related Disorders ·Dejan Jakimovski, (unknown), Jesper Hagemeier, Deepa P. Ramasamy, Niels Bergsland, Michael G. Dwyer, Svetlana Eckert, Channa Kolb, (unknown), David Hojnacki, Bianca Weinstock‐Guttman, Robert Zivadinov	14
7	No association between variations in extracranial venous anatomy and clinical outcomes in multiple sclerosis patients over 5 years 2019 ·BMC Neurology ·Sirin Gandhi, Karen Marr, Marcello Mancini, Maria Grazia Caprio, Dejan Jakimovski, Avinash Chandra, Jesper Hagemeier, David Hojnacki, Channa Kolb, Bianca Weinstock‐Guttman, Robert Zivadinov	4
8	Response heterogeneity to home-based restorative cognitive rehabilitation in multiple sclerosis: An exploratory study 2019 ·Multiple Sclerosis and Related Disorders ·Tom Fuchs, Stefano Ziccardi, Michael G. Dwyer, Leigh Charvet, (unknown), (unknown), (unknown), David Hojnacki, (unknown), (unknown), (unknown), Michael Shaw, Curtis Wojcik, (unknown), Bianca Weinstock‐Guttman, Robert Zivadinov, Ralph H. B. Benedict	30
9	Dicer and microRNA expression in multiple sclerosis and response to interferon therapy 2016 ·Journal of Neuroimmunology ·William J. Magner, Bianca Weinstock‐Guttman, Mina Rho, David Hojnacki, (unknown), Murali Ramanathan, Thomas B. Tomasi	28
10	Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis 2013 ·BMC Medicine ·Ralph H. B. Benedict, (unknown), Karen Marr, (unknown), Cheryl Kennedy, Ellen Carl, (unknown), David Hojnacki, Robert Zivadinov	7
11	Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: Results of the PREMiSe pilot study 2013 ·BMC Neurology ·Robert Zivadinov, Yuval Karmon, Krešimir Dolić, Jesper Hagemeier, Karen Marr, (unknown), Cheryl Kennedy, David Hojnacki, Ellen Carl, L. Nelson Hopkins, Elad I. Levy, Bianca Weinstock‐Guttman, Adnan H. Siddiqui	14
12	Comparison of Intravascular Ultrasound with Conventional Venography for Detection of Extracranial Venous Abnormalities Indicative of Chronic Cerebrospinal Venous Insufficiency 2013 ·Journal of Vascular and Interventional Radiology ·Yuval Karmon, Robert Zivadinov, Bianca Weinstock‐Guttman, Karen Marr, (unknown), Krešimir Dolić, Cheryl Kennedy, David Hojnacki, Ellen Carl, Jesper Hagemeier, L. Nelson Hopkins, Elad I. Levy, Adnan H. Siddiqui	22
13	Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis 2012 ·BMC Neurology ·Bianca Weinstock‐Guttman, Murali Ramanathan, Karen Marr, David Hojnacki, Ralph H. B. Benedict, Charity J. Morgan, (unknown), Ellen Carl, Cheryl Kennedy, (unknown), (unknown), (unknown), (unknown), Michelle Andrews, Robert Zivadinov	16
14	Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy 2012 ·American Journal of Neuroradiology ·Jesper Hagemeier, Bianca Weinstock‐Guttman, Niels Bergsland, Mari Heininen‐Brown, Ellen Carl, Cheryl Kennedy, Christopher Magnano, David Hojnacki, Michael G. Dwyer, (unknown)	52
15	Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients. 2012 ·PubMed ·(unknown), Sara Hussein, Cheryl Kennedy, B. Weinstock‐Guttman, David Hojnacki, Robert Zivadinov	5
16	Sensitivity and specificity for screening of chronic cerebrospinal venous insufficiency using a multimodal non-invasive imaging approach in patients with multiple sclerosis. 2012 ·PubMed ·(unknown), Karen Marr, (unknown), Michael G. Dwyer, Ellen Carl, Jesper Hagemeier, Cheryl Kennedy, (unknown), Colleen Kilanowski, (unknown), David Hojnacki, B. Weinstock‐Guttman, Robert Zivadinov	24
17	Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency 2011 ·BMC Neurology ·Robert Zivadinov, Guy Poloni, Karen Marr, Claudiu Schirda, Christopher Magnano, Ellen Carl, Niels Bergsland, David Hojnacki, Cheryl Kennedy, Clive Beggs, Michael G. Dwyer, Bianca Weinstock‐Guttman	48
18	Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS 2011 ·Neurology ·Robert Zivadinov, Karen Marr, Gary Cutter, Murali Ramanathan, Ralph H. B. Benedict, (unknown), (unknown), E. Ann Yeh, (unknown), Charles M. Brooks, (unknown), (unknown), Ellen Carl, Michael G. Dwyer, David Hojnacki, Bianca Weinstock‐Guttman	151
19	Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report 2011 ·BMC Medicine ·Paolo Zamboni, Erica Menegatti, Bianca Weinstock‐Guttman, Michael G. Dwyer, Claudiu Schirda, Anna Maria Malagoni, David Hojnacki, Cheryl Kennedy, Ellen Carl, Niels Bergsland, Christopher Magnano, Ilaria Bartolomei, Fabrizio Salvi, Robert Zivadinov	73
20	Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis 2009 ·Multiple Sclerosis Journal ·(unknown), Bianca Weinstock‐Guttman, F Munschauer, David Hojnacki, (unknown)	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact